Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death

Oncotarget

Volumn 6, Issue 27, 2015, Pages 24393-24403

  Kwon, Min Young ^a   Park, Eunhee ^a   Lee, Seon Jin ^b   Chung, Su Wol ^a  

^a University of Ulsan   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Free radicals; Heme oxygenase 1; Iron; Oncogene; Oncology

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; BILIVERDIN; CHONDROITIN SULFATE IRON; DEFEROXAMINE; ERASTIN; HEME OXYGENASE 1; HEMIN; PROTOPORPHYRIN ZINC; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; BILIRUBIN; CYCLOHEXIMIDE; HMOX1 PROTEIN, HUMAN; HMOX1 PROTEIN, MOUSE; IRON; MEMBRANE PROTEIN; PIPERAZINE DERIVATIVE; PROTOPORPHYRIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG POTENTIATION; FERROPTOSIS; FIBROSARCOMA; FIBROSARCOMA CELL LINE; IN VITRO STUDY; IRON CHELATION; LIPID PEROXIDATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; ANIMAL; BAGG ALBINO MOUSE; CELL NUCLEUS; CHEMISTRY; FIBROBLAST; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; BILIRUBIN; BILIVERDINE; CELL DEATH; CELL LINE, TUMOR; CELL NUCLEUS; CYCLOHEXIMIDE; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEME OXYGENASE-1; HEMIN; HUMANS; IRON; LIPID PEROXIDATION; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PIPERAZINES; PROTOPORPHYRINS; REACTIVE OXYGEN SPECIES;

EID: 84943390843     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5162     Document Type: Article

References (30)

1. Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 2011;147:742-758.
2. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
3. Vigil D, Cherfils J, Rossman KL, Der CJ. Ras superfamily GEFs and GAPs:validated and tractable targets for cancer therapy? Nat. Rev. Cancer. 2010;10:842-857.
4. Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285-296.
5. Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15:234-245.
6. Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ. RAS-RAF-MEK-dependent oxidative cell death involving voltagedependent anion channels. Nature. 2007;447:864-868.
7. Wolpaw AJ, Shimada K, Skouta R, Welsch ME, Akavia UD, Pe'er D, Shaik F, Bulinski JC, Stockwell BR. Modulatory profiling identifies mechanisms of small molecule-induced cell death. Proc Natl Acad Sci USA. 2011;108:E771-E780.
8. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS. Ferroptosis:an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060-1072.
9. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA. 1968;61:748-755.
10. Tenhunen R, Marver H Schmid R. Microsomal heme oxygenase, characterization of the enzyme. J Biol Chem. 1969; 244:6388-6394.
11. Ryter SW, Choi AM. Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy. Am J Respir Cell Mol Biol. 2009;41:251-260.
12. Ferrándiz ML, Devesa I. Inducers of heme oxygenase-1. Curr Pharm Des. 2008;14:473-486.
13. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1:unleashing the protective properties of heme. Trends Immunol. 2003;24:449-455.
14. Gueron G, Giudice J, Valacco P, Paez A, Elguero B, Toscani M, Jaworski F, Leskow FC, Cotignola J, Marti M, Binaghi M, Navone N, Vazquez E. Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cells. Oncotarget. 2014;5:4087-4102.
15. Andrés NC, Fermento ME, Gandini NA, Romero AL, Ferro A, Donna LG, Curino AC, Facchinetti MM. Heme oxygenase-1 has antitumoral effects in colorectal cancer: Involvement of p53. Exp Mol Pathol. 2014;97:321-331.
16. Yin H, Fang J, Liao L, Maeda H, Su Q. Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity. BMC Cancer. 2014; 14:436.
17. Li C, Lönn ME, Xu X, Maghzal GJ, Frazer DM, Thomas SR, Halliwell B, Richardson DR, Anderson GJ, Stocker R. Sustained expression of heme oxygenase-1 alters iron homeostasis in nonerythroid cells. Free Radic Biol Med. 2012;53:366-374.
18. Kadir FH, al-Massad FK, Moore GR. Haem binding to horse spleen ferritin and its effect on the rate of iron release. Biochem J. 1992;282:867-870.
19. Skouta R, Hayano M, Shimada K, Stockwell BR. Dsign and synthesis of Pictet-Spengler condensation products that exhibit oncogenic-RAS synthetic lethality and induce non-apoptotic cell death. Bioorg Med Chem Lett. 2012; 22:5707-5713.
20. Immenschuh S, Baumgart-Vogt E, Mueller S. Heme oxygenase-1 and iron in liver inflammation:a complex alliance. Curr Drug Targets. 2010;11:1541-1550.
21. Lanceta L, Li C, Choi AM, Eaton JW. Haem oxygenase-1 overexpression alters intracellular iron distribution. Biochem J. 2013;449:189-194.
22. Weïwer M, Bittker JA, Lewis TA, Shimada K, Yang WS, MacPherson L, Dandapani S, Palmer M, Stockwell BR, Schreiber SL, Munoz B. Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg Med Chem Lett. 2012;22:1822-1826.
23. Christofferson DE, Yuan J. Cyclophilin A release as a biomarker of necrotic cell death. Cell Death Differ. 2010; 17:1942-1943.
24. Christofferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol. 2010; 22:263-268.
25. Perrella MA, Yet SF. Role of heme oxygenase-1 in cardiovascular function. Curr Pharm Des. 2003; 9:2479-2487.
26. Nishimura K, Tokida M, Katsuyama H, Nakagawa H, Matsuo S. The effect of hemin-induced oxidative stress on erythropoietin production in HepG2 cells. Cell Biol Int. 2014;38:1321-1329.
27. Lin Y, Zhang W, Qi F, Cui W, Xie Y, Shen W. Hydrogenrich water regulates cucumber adventitious root development in a heme oxygenase-1/carbon monoxide-dependent manner. J Plant Physiol. 2014;171:1-8.
28. Li H, Wood JT, Whitten KM, Vadivel SK, Seng S, Makriyannis A, Avraham HK. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells. Br J Pharmacol. 2013;170:489-505.
29. Sahin K, Tuzcu M, Gencoglu H, Dogukan A, Timurkan M, Sahin N, Aslan A, Kucuk O. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci. 2010;87:240-245.
30. Sasaki T, Yoshida K, Kondo H, Ohmori H, Kuniyasu H. Heme oxygenase-1 accelerates protumoral effects of nitric oxide in cancer cells. Virchows Arch. 2005; 446:525-531.